Skip to Content

Mupirocin Calcium 2% Nasal Ointment

Last Updated: January 10, 2018
Status: Resolved

Mupirocin Calcium 2% Nasal Ointment

Products Affected - Description
  • Bactroban 2% nasal ointment, GlaxoSmithKline
    1 gram tube, 10 count (NDC 00029-1526-11)

Reason for the Shortage
  • GlaxoSmithKline states the shortage is due to manufacturing issues. GlaxoSmithKline is looking for an alternative supply source.1

Available Products
  • There are no presentations available.

Estimated Resupply Dates

  • GlaxoSmithKline has Bactroban Nasal 2% Ointment in 1 gram tubes on long-term back order and the company cannot estimate a release date.1

Implications for Patient Care

  • Mupirocin calcium ointment is used intranasally to eradicate nasal colonization of methicillin-resistant Staphylococcus aureus in adult patients and healthcare workers during institutional outbreaks to reduce the risk of infection.2


  • Do not share tubes of mupirocin ointment between patients to minimize the risk of cross-contamination.

Alternative Agents & Management

  • During this shortage, consider using mupirocin ointment instead of mupirocin calcium ointment.


    1. GlaxoSmithKline (personal communications). August 5, November 7, 2016; January 27, February 14, May 22, July 28, November 3, 2017; and January 10, 2018.
    2. GlaxoSmithKline. Bactroban Nasal (mupirocin calcium) ointment 2% [product labeling]. Research Triangle Park, NC: GlaxoSmithKline; 2015.


Updated January 10, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 13, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.